ABUS

#2160
Arbutus Biopharma Corporation Common Stock
4.66
-0.64%
Secteur:
Base:
Devise de Profit:
Range quotidien
4.66
4.66
Range Annuel
2.71
5.10
Changement quotidien
-0.64%
Changement Mensuel
+11.75%
Evolution sur 6 mois
+27.32%
Changement Annuel
+38.69%
Clôture Précédente
4.69
Open
4.66
Bid
Ask
Low
4.66
High
4.66
Volume
230
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 893.69 M
  • Employee 44
  • Founded 2007
  • CEO William H. Collier
  • Website www.arbutusbio.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000RR8V85
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-19.74
Price to sales ratio
59.49
Dividends per share
—
Dividend yield %
—

Arbutus Biopharma Corporation

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.

Nouvelles